Patrick Daly

DocwireNews

In an analysis of race/ethnicity outcomes in myeloproliferative neoplasms (MPN), data suggest that Non-Hispanic Whites (NHW) and Hispanics (H) respond similarly to hematopoietic stem cell transplantation (HCT). The study was presented at the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting.To conduct this study, Snegha Ananth and colleagues initially focused on 45 patients with MPN in San Antonio, TX, who underwent HCT disorders from January 2008 to December 2000. The final analysis was comprised of 19 NHW patients and 19 H patients. Race was self-reported, and the investigative team procured background data from electronic medical records. Chi-square tests and the Kaplan-Meier method were used to compare data between races and assess for overall survival (OS).The study found that H patients were on average younger at time of transplant compared to NHW (52 years of age vs. 62 years of age), and more likely to have a haploidentical donor (47% vs. 11%). However, the researchers observed no appreciable differences between NHW and H patients as pertaining to performance status, conditioning regimen, stem cell source, and Graft-versus-host disease (GvHD) prophylaxis. Moreover, there were no significant differences in total time to neutrophil or platelet recovery, and no marked differences in cumulative incidence of acute GvHD. Furthermore, the analysis found no significant difference in relapse mortality and non-relapse mortality between the two groups.The researchers concluded that: &ldquo;NHW and H had comparable relapse, non-relapse and survival rates likely due to similar access to treatment and follow-up within a single institution.&rdquo; They added that larger and prospective studies are needed &ldquo;to further elucidate this important topic.&rdquo;

Bradley Marder, MD

Joel M. Topf, MD, FACP

Gout Studies: Transplant Waitlisting and Bone Erosion

NKF Spring Clinical Meetings 2025

Jayme Locke, MD, MPH

The Promise of Xenotransplantation

Leah Lawrence

Real-World Data Backs Invasive DFS as Surrogate Endpoint for OS in EBC

HR Breast Cancer

Latest News

Assessing Race-Related Outcomes in Hematopoietic Stem Cell Transplantation in Myeloproliferative Neoplasms

ASCO 2022

In an analysis of race/ethnicity outcomes in myeloproliferative neoplasms (MPN), data suggest that Non-Hispanic Whites (NHW) and Hispanics (H) respond similarly to ...

Assessing Race-Related Outcomes in Hematopoietic Stem Cell Transplantation in Myeloproliferative

About Us

Editorial Policy

Advertising

Contact Us

eNewsletters

Contribute

Career Center

MashupMD

Blood Cancers Today

Cancer Nursing Today

GU Oncology Now

Urban Health Today

Bile Duct Cancer

Colorectal Cancer

Gastroesophageal Cancer

Gastric Cancer

GEP-NETs

GIST

Liver Cancer

Pancreatic Cancer

GI Oncology Now

Anemia

Deep Vein Thrombosis

Essential Thrombocythemia

Hemophilia

Immune Thrombocytopenic Purpura

Myelodysplastic Syndromes

Myelofibrosis

Myeloproliferative Neoplasms

Polycythemia Vera

Pulmonary Embolism

Sickle Cell Disease

Thrombocytopenia

Thrombophilia

Thrombosis

Thrombotic Thrombocytopenic Purpura

Venous Thromboembolism

von Willebrand Disease

Heme Today

Acute Kidney Injury

ADPKD

Anemia and Kidney Disease

Chronic Kidney Disease

COVID-19 and Kidney Disease

Diabetes and Hypertension

End-Stage Renal Disease

Gout

Hyperkalemia

IgAN

Kidney Transplantation

Metabolic Acidosis

Nephrology Times

HER2 Breast Cancer

Triple-Negative Breast Cancer

Genetics & Breast Cancer

Breast Cancers Today

Atherosclerotic Disease

Atrial Fibrillation

Heart Failure

Hypertension

Interventional Cardiology

Lipid Management

Practice Tips With Dr. Lichaa

Preventive Cardiology

Stroke

Cardiology

Breast Cancer

Gynecologic Cancer

Head and Neck Cancer

Skin Cancer

Oncology

Sleep

Urology

Diabetes

Ophthalmology

— Demodex Blepharitis

Neurology

Rheumatology

Gastroenterology

Pulmonology

Infectious Diseases

— HIV

Health and Wellness

Lupus

Future of Medicine

Orthopedics

Pharmacology

Career News

More

Conferences

CardioNerds

The Sleep Source With Dr. Morse

Rheumatology Rounds With Dr. Maheswaranathan

Partners

Expert Interviews

Subscribe